Straits Times Index
3,293.83 -3.06 (-0.09%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,202.01 +29.86 (+0.37%) Bitcoin USD
59,321.26 +1,533.55 (+2.65%) CMC Crypto 200
1,283.72 +6.74 (+0.53%)
AMGN Jun 2025 195.000 put
| Previous close | 5.35 |
| Open | 5.35 |
| Bid | 4.55 |
| Ask | 6.20 |
| Strike | 195.00 |
| Expiry date | 2025-06-20 |
| Day's range | 5.35 - 5.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 48 |
- Yahoo Finance Video
Amgen, DraftKings, Live Nation: Trending tickers
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology giant's revenue rose by 22% during the quarter. DraftKings (DKNG) also delivered a strong earnings report, surpassing analysts' estimates on both the top and bottom lines. Buoyed by this performance, the company raised its full-year outlook. Live Nation (LYV) topped revenue estimates in its first quarter earnings, although the company reported a loss of $0.53 per share. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
- GuruFocus.com
Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
Amgen reports a 22% revenue increase and significant progress in rare disease treatments and pipeline development.
ZacksHere's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
The headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
